Details of the Drug
General Information of Drug (ID: DMMU1CQ)
Drug Name |
2-amino-2-(3-chloro-4-fluorophenyl)acetic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
261762-99-6; 2-amino-2-(3-chloro-4-fluorophenyl)acetic acid; 3-Chloro-4-fluoro-DL-phenylglycine; C8H7ClFNO2; CHEMBL203905; amino(3-chloro-4-fluorophenyl)acetic acid; AC1MCND8; SCHEMBL8196588; KS-00000ZXX; CTK8F0591; DTXSID40378674; MolPort-000-153-073; JRD-1093; SBB093187; BDBM50179692; 8653AD; 2-(3-Chloro-4-fluorophenyl)glycine; MFCD01631397; AKOS032962888; AKOS015907725; MCULE-4108995551; RTR-011871; PS-6305; SY044823; TR-011871; ST51041478; FT-0676194; MFCD01631397 (95%); C-5924
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 203.6 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||